Replies to post #2641 on Skye Bioscience Inc (SKYE)

[AntonChigurh]

i got 50m from this website

https://www.pharmacompass.com/prescriptions/dronabinol but it does say 'drug cost' and not 'drug sales'.

the PR firm said this:

'Thank you for pointing out the discrepancy in the molecule identifiers. To clarify, Nemus is developing a prodrug of THC and an analogue of CBD.

The NB1XXX series refers to the prodrug of THC based candidates: NB1111 for glaucoma and NB1222 for CINV.

The NB2XXX series refers to the analogue of CBD based candidates: NB2111 for CIPN/pain and NB2222 for ocular conditions.

There is a table on the current company website that delineates the pipeline molecules as well as the projected market size for the target conditions.

We apologize for the confusion and the company will correct the press release on its website.'